Aptamer-mediated hollow MnO(2) for targeting the delivery of sorafenib

Sorafenib (SRF) presents undesirable effects in clinical treatment, due to the lack of targeting, poor water solubility, and obvious side effects. In this study, we constructed a novel nanodrug carrier system for accurate and efficient delivery of SRF, improving its therapeutic effects and achieving...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ziyue, Wu, Cuicui, Liu, Jinren, Hu, Shunxin, Yu, Junli, Yin, Qiangqiamg, Tian, Hongda, Ding, Zhipeng, Qi, Guiqiang, Wang, Li, Hao, Liguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721444/
https://www.ncbi.nlm.nih.gov/pubmed/36457288
http://dx.doi.org/10.1080/10717544.2022.2149897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721444/
https://www.ncbi.nlm.nih.gov/pubmed/36457288
http://dx.doi.org/10.1080/10717544.2022.2149897

Ejemplares similares